AptaTargets is a biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. AptaTargets drug candidates start at preclinical stages and aims to reach phase 2 of clinical trials. Our candidates come from R&D activities developed at parent company Aptus Biotech in collaboration with research centers of reference.

AptaTargets starts its activity with a set of candidates for Acute Stroke treatment. These aptamers have been identified in vitro and their efficacy has been validated through in vitro and in vivo studies with outstanding results.


Instituto Ramón y Cajal de Investigación sanitaria Universidad Complutense Madrid UIN ABG Patentes Centro de Desarrollo Tecnológico Industrial